A contributing issue is how long before it can be reapplied to...

A contributing issue is how long before it can be reapplied to the same skin area without irritation and how much irritation and penetration in that reused skin are . A larger patch especially for longer term use quickly limit areas where it may be applied especially if only certain skin areas are suitable . That goes to what they are treating and the length of time for treatment etc. There is a lot of factors at play.

They have probably picked something that they believed their shareholders would believe as agreed by the counterparty to create a announcement that give no detailed information of their real progress or lack of. . It seems a very small amount of $ spent or I might not be understanding if they is the total amount expended by the partnership.